These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4014780)

  • 21. Sensitization to house dust mites in Reykjavik, Iceland, in the absence of domestic exposure to mites.
    Hallas TE; Gislason D; Björnsdottir US; Jörundsdottir KB; Janson C; Luczynska CM; Gislason T
    Allergy; 2004 May; 59(5):515-9. PubMed ID: 15080832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts.
    Casanovas M; Martín R; Jiménez C; Caballero R; Fernández-Caldas E
    Clin Exp Allergy; 2007 Mar; 37(3):434-40. PubMed ID: 17359393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Housedust mite culture medium: an alternative source for the production of allergenic extracts].
    López RI; Lynch NR; Di Prisco MC; Garcia NM
    Acta Cient Venez; 1996; 47(2):103-9. PubMed ID: 9433826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. House dust and forage mite allergens and their role in human and canine atopic dermatitis.
    Nuttall TJ; Hill PB; Bensignor E; Willemse T;
    Vet Dermatol; 2006 Aug; 17(4):223-35. PubMed ID: 16827665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An evaluation of the long-term effect of clustered immunotherapy in house-dust-mite-sensitive adult bronchial asthma].
    Nagata M; Tanaka K
    Arerugi; 2001 May; 50(5):435-9. PubMed ID: 11436329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevalence of various pneumo-allergens among the positives in global in vitro diagnostic tests for allergy; possible importance of restricted mixtures].
    Dumontet M
    Allerg Immunol (Paris); 1993 May; 25(5):193-7. PubMed ID: 8318146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Predicting the clinical efficacy of house dust mite immunotherapy in bronchial asthmatics by multiple quantification analysis type II].
    Soda R; Okada C; Takahashi K; Katagi S; Kanehiro A; Kimura G; Okamoto S; Tada S; Kimura I
    Arerugi; 1993 Dec; 42(12):1771-5. PubMed ID: 8110037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in potency of extracts used for allergy skin tests.
    Hillas JL; Wilson JD
    N Z Med J; 1981 Jul; 93(687):2-4. PubMed ID: 6943460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of skin reactions to aeroallergens in asthmatics of Puerto Rico.
    Montealegre F; Quiñones C; Michelen V; Bayona M; Fernández-Caldas E; Vazques O; Colón F; Chardón D; García M
    P R Health Sci J; 1997 Dec; 16(4):359-67. PubMed ID: 9580406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Specific skin reactions induced by individual pollen preparations in hypersensitivity persons].
    Paranos S; Petrović S; Vojović I
    Srp Arh Celok Lek; 1998; 126(9-10):362-7. PubMed ID: 9863408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of efficacy and safety of intrabronchial specific immunotherapy with allergy medication against allergies to house mites among patients with bronchial asthma].
    Zietkowski Z
    Pol Merkur Lekarski; 1999 May; 6(35):239-41. PubMed ID: 10437390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality parameters for the production of mite extracts.
    Eraso E; Martínez J; Martínez A; Palacios R; Guisantes JA
    Allergol Immunopathol (Madr); 1997; 25(3):113-7. PubMed ID: 9208047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standardized extracts, dust mite, and other arthropods (inhalants).
    Ford AW; Platts-Mills TA
    Clin Rev Allergy; 1987 Feb; 5(1):49-73. PubMed ID: 2435397
    [No Abstract]   [Full Text] [Related]  

  • 35. Sublingual immunotherapy: recent advances.
    Compalati E; Braido F; Walter Canonica G
    Allergol Int; 2013 Dec; 62(4):415-23. PubMed ID: 24280671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State of the art in developing allergen vaccines in Cuba: prospects of novel adjuvanted vaccines.
    Labrada A; Facenda E; Castro RL; Fernández B; Uyema K; Sewer M; Aranda RE; Más A; Navarro B; Jorge O; Novoa I; Díaz J; Bourg V
    Vaccine; 2006 Apr; 24 Suppl 2():S2-36-7. PubMed ID: 16823917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety considerations in assessing the role of immunotherapy in allergic disorders.
    Bousquet J; Michel FB
    Drug Saf; 1994 Jan; 10(1):5-17. PubMed ID: 8136087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical characterisation of mite allergoids and alum-adsorbed mite allergoids.
    Luykx D; Cordewener J; de Bruijn J; Westphal A; Sleijster H; America T; van den Hout R
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2013; 97():97-100. PubMed ID: 24912319
    [No Abstract]   [Full Text] [Related]  

  • 39. Serological technique: immunotherapy; immunization against pollen, foodstuffs, house dust, etc.
    GREVAL SD
    Ind Med Gaz; 1951 Feb; 86(2):47-8; contd. PubMed ID: 14850126
    [No Abstract]   [Full Text] [Related]  

  • 40. Serological technique: immunotherapy; immunization against pollen, foodstuffs, house dust, etc.
    GREVAL SD
    Ind Med Gaz; 1951 Jan; 86(1):17-8; contd. PubMed ID: 14831945
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.